Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1980 Jun;65(6):1398–1406. doi: 10.1172/JCI109804

Decreased Lysosomal Dipeptidyl Aminopeptidase I Activity in Cultured Human Skin Fibroblasts in Duchenne's Muscular Dystrophy

Benjamin B Gelman 1, Linda Papa 1, Michael H Davis 1, Eric Gruenstein 1
PMCID: PMC371478  PMID: 6773986

Abstract

Several lysosomal enzymes were assayed in cultured human skin fibroblasts from patients with Duchenne's muscular dystrophy (DMD) and age- and sex-matched control patients (N). The activity of four glycosidases, cathepsin B1, and total autoproteolysis at pH 4.0 were unchanged between the groups, but dipeptidyl aminopeptidase I (DAP-I, or cathepsin C) in the DMD cells was found to be only 30% as active as in the control cells (P < 0.003). This difference is not the result of a redistribution or loss of enzyme during homogenization because the difference occurs in all homogenate fractions. DAP-I activity existing in N and DMD fibroblasts behaves identically with respect to activation by chloride ion, activation by the sulfhydryl reducing agent dithiothreitol, changes in hydrogen ion concentration (pH), changes in substrate concentration (i.e., apparent Km values), and changes in temperature (i.e., apparent activation energies). Mixtures of N and DMD cell sonicates display an additivity in DAP-I activity. These results support the conclusion that the catalytic function of the DAP-I molecule is equivalent between N and DMD fibroblasts, and that the decrease in tissue-specific DAP-I activity probably results from the fact that fewer enzyme molecules are present in the DMD cells. These results are also an indication that these nonmuscle cells are expressing some of the phenotypic aspects of the genetic defect in DMD. Cultured human skin fibroblasts may therefore be a useful cellular model in DMD research.

Full text

PDF
1398

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cullen M. J., Parsons R. Inclusion bodies in muscular dystrophy. Lancet. 1977 Oct 29;2(8044):929–929. doi: 10.1016/s0140-6736(77)90862-5. [DOI] [PubMed] [Google Scholar]
  2. Ionasescu V., Lara-Braud C., Zellweger H., Ionasescu R., Burmeister L. Fibroblast cultures in Duchenne muscular dystrophy. Alterations in synthesis and secretion of collagen and noncollagen proteins. Acta Neurol Scand. 1977 May;55(5):407–417. doi: 10.1111/j.1600-0404.1977.tb05659.x. [DOI] [PubMed] [Google Scholar]
  3. Ionasescu V., Zellweger H., Ionasescu R., Lara-Braud C., Cancilla P. A. Protein synthesis in muscle cultures from patients with Duchenne muscular dystrophy. Calcium and A23187 ionophore dependent changes. Acta Neurol Scand. 1976 Sep;54(3):241–247. doi: 10.1111/j.1600-0404.1976.tb04800.x. [DOI] [PubMed] [Google Scholar]
  4. Kar N. C., Pearson C. M. A calcium-activated neutral protease in normal and dystrophic human muscle. Clin Chim Acta. 1976 Dec 1;73(2):293–297. doi: 10.1016/0009-8981(76)90175-3. [DOI] [PubMed] [Google Scholar]
  5. Kar N. C., Pearson C. M. Acid, neutral and alkaline cathepsins in normal and diseased human muscle. Enzyme. 1972;13(4):188–196. doi: 10.1159/000459660. [DOI] [PubMed] [Google Scholar]
  6. Kar N. C., Pearson C. M. Activity of some proteolytic enzymes in normal and dystrophic human muscle. Clin Biochem. 1979 Apr;12(2):37–39. doi: 10.1016/s0009-9120(79)80001-6. [DOI] [PubMed] [Google Scholar]
  7. Kar N. C., Pearson C. M. Dipeptidyl peptidases in human muscle disease. Clin Chim Acta. 1978 Jan 2;82(1-2):185–192. doi: 10.1016/0009-8981(78)90042-6. [DOI] [PubMed] [Google Scholar]
  8. Katunuma N., Yasogawa N., Kito K., Sanada Y., Kawai H., Miyoshi K. Abnormal expression of a serine protease in human dystrophic muscle. J Biochem. 1978 Feb;83(2):625–628. doi: 10.1093/oxfordjournals.jbchem.a131950. [DOI] [PubMed] [Google Scholar]
  9. Kunze D., Reichmann G., Egger E., Olthoff D., Döhler K. Fatty acid pattern of lipids in normal and dystrophic human muscle. Eur J Clin Invest. 1975 Nov 21;5(6):471–475. doi: 10.1111/j.1365-2362.1975.tb00479.x. [DOI] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Mawatari S., Miranda A., Rowland L. P. Adenyl cyclase abnormality in Duchenne muscular dystrophy: muscle cells in culture. Neurology. 1976 Nov;26(11):1021–1026. doi: 10.1212/wnl.26.11.1021. [DOI] [PubMed] [Google Scholar]
  12. Mayer M., Shafrir E. Skeletal muscle protease and glucocorticoid hormone receptors in muscle wasting conditions and muscular dystrophy. Isr J Med Sci. 1977 Feb;13(2):139–146. [PubMed] [Google Scholar]
  13. McDonald J. K., Zeitman B. B., Reilly T. J., Ellis S. New observations on the substrate specificity of cathepsin C (dipeptidyl aminopeptidase I). Including the degradation of beta-corticotropin and other peptide hormones. J Biol Chem. 1969 May 25;244(10):2693–2709. [PubMed] [Google Scholar]
  14. McKeran R. O., Halliday D., Purkiss P. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine. J Neurol Neurosurg Psychiatry. 1977 Oct;40(10):979–981. doi: 10.1136/jnnp.40.10.979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Metroione R. M., Neves A. G., Fruton J. S. Purification and properties of dipeptidyl transferase (Cathepsin C). Biochemistry. 1966 May;5(5):1597–1604. doi: 10.1021/bi00869a021. [DOI] [PubMed] [Google Scholar]
  16. Mokri B., Engel A. G. Duchenne dystrophy: electron microscopic findings pointing to a basic or early abnormality in the plasma membrane of the muscle fiber. Neurology. 1975 Dec;25(12):1111–1120. doi: 10.1212/wnl.25.12.1111. [DOI] [PubMed] [Google Scholar]
  17. Pena S. D., Vust A., Tucker D., Hamerton J. L., Wrogemann K. Biochemical investigations in cultured skin fibroblasts from patients with Duchenne muscular dystrophy. Clin Genet. 1978 Jul;14(1):50–54. doi: 10.1111/j.1399-0004.1978.tb02060.x. [DOI] [PubMed] [Google Scholar]
  18. Peters T. J., Müller M., De Duve C. Lysosomes of the arterial wall. I. Isolation and subcellular fractionation of cells from normal rabbit aorta. J Exp Med. 1972 Nov 1;136(5):1117–1139. doi: 10.1084/jem.136.5.1117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Pickard N. A., Gruemer H. D., Verrill H. L., Isaacs E. R., Robinow M., Nance W. E., Myers E. C., Goldsmith B. Systemic membrane defect in the proximal muscular dystrophies. N Engl J Med. 1978 Oct 19;299(16):841–846. doi: 10.1056/NEJM197810192991601. [DOI] [PubMed] [Google Scholar]
  20. Rome L. H., Garvin A. J., Allietta M. M., Neufeld E. F. Two species of lysosomal organelles in cultured human fibroblasts. Cell. 1979 May;17(1):143–153. doi: 10.1016/0092-8674(79)90302-7. [DOI] [PubMed] [Google Scholar]
  21. Schotland D. L., Bonilla E., Van Meter M. Duchenne dystrophy: alteration in muscle plasma membrane structure. Science. 1977 May 27;196(4293):1005–1007. doi: 10.1126/science.860127. [DOI] [PubMed] [Google Scholar]
  22. Takahashi K., Takao H., Takai T. Adenylate cyclase in Duchenne and Fukuyama type muscular dystrophy. Kobe J Med Sci. 1978 Dec;24(4):193–198. [PubMed] [Google Scholar]
  23. West D. P., Ellis D. A., Strickland J. M. Incorporation of [U-14C]glucose into neutral lipids and sn-glycerol-3-phosphate in muscle from Duchenne muscular dystrophy and control patients. J Neurol Sci. 1977 Aug;33(1-2):131–142. doi: 10.1016/0022-510x(77)90187-3. [DOI] [PubMed] [Google Scholar]
  24. Wyatt P. R., Cox D. M. Duchenne's muscular dystrophy: studies in cultured fibroblasts. Lancet. 1977 Jan 22;1(8004):172–174. doi: 10.1016/s0140-6736(77)91768-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES